Dietetic composition
Abstract
(Problems) To provide a highly safe dietetic composition originating in green coffee beans by which excellent dietetic effects can be obtained and which contributes to the prevention and treatment of life style-related diseases such as diabetes. (Means for Solving Problems) A dietetic composition characterized by comprising, as the active ingredient, a polar solvent extract of defatted green coffee beans. It is preferable that the above-described polar solvent extract is an extract obtained by using water-containing ethanol, still preferably water-containing ethanol having an ethanol concentration of from 40 to 90% (wt/wt). It is preferable that the above-described defatted green coffee beans are those obtained by extracting green coffee beans with N-hexane to thereby separate oily components therefrom. It is recommended to combine the above-described dietetic composition with one or more members selected from among salacia extract, evening primrose extract, sesamine and garcinia. This dietetic composition is usable as a material for foods, drinks, drugs, or skin preparations for external use.
Claims
exact text as granted — not AI-modified1 . A dietetic composition characterized by comprising a polar solvent extract as an active substance derived from the defatted green coffee beans.
2 . A dietetic composition of claim 1 , therein the aforementioned polar solvent extract is a hydroethanol extract.
3 . A dietetic composition of claim 1 , therein the aforementioned polar solvent extract is a hydroethanol extract having an ethanol concentration of 40 to 90% (wt/wt).
4 . A dietetic composition of claim 1 , therein the aforementioned defatted green coffee bean is prepared by extracting and separating the oil from the green coffee beans with N-hexane.
5 . A dietetic composition described in claim 1 , which is formed by adding one or more substances from among salacia extract, evening primrose extract, sesamin, and garcinia.
6 . A food and drink comprising a dietetic composition as an active substance described in claim 1 .
7 . A medicine comprising a dietetic composition as an active substance described in claim 1 .
8 . A medicine for external use comprising a dietetic composition as an active substance described in claim 1 .
9 . A composition for suppressing the fat absorption characterized by comprising the green coffee bean extract as an active substance.
10 . A composition for suppressing the fat absorption described in claim 9 , therein the aforementioned green coffee bean extract is a polar solvent extract derived from the defatted green coffee beans,
11 . A composition for suppressing the fat absorption described in claim 10 , therein the polar solvent extract is a hydroethanol extract.
12 . A composition for suppressing the fat absorption described in claim 10 , therein the polar solvent extract is a hydroethanol extract having an ethanol concentration of 40 to 90% (wt/wt).
13 . A composition for suppressing the fat absorption described in claim 10 , therein the defatted green coffee bean is prepared by extracting and separating the oil from the green coffee bean with N-hexane.
14 . A food and drink comprising a composition as an active substance for suppressing the fat absorption described in claim 9 .
15 . A medicine comprising a composition as an active substance for suppressing the fat absorption described in claim 9 .
16 . A composition for inhibiting the pancreatic lipase activity comprising the green coffee bean extract as an active substance.
17 . A composition for inhibiting the pancreatic lipase activity of claim 9 , therein the green coffee bean extract is a polar solvent extract derived from the defatted green coffee bean.
18 . A composition for inhibiting the pancreatic lipase activity of claim 17 , therein the polar solvent extract is a hydroethanol extract.
19 . A composition for inhibiting the pancreatic lipase activity of claim 17 , therein the polar solvent extract is a hydroethanol extract having an ethanol concentration of 40 to 90% (wt/wt).
20 . A composition for inhibiting the pancreatic lipase activity of claim 17 , therein the defatted green coffee bean is prepared by extracting and separating the oil from the green coffee bean with N-hexane.
21 . A food and drink comprising a composition as an active substance for inhibiting the pancreatic lipase activity described in claim 16 .
22 . A medicine comprising a composition as an active substance for inhibiting the pancreatic lipase activity described in claim 16 .
23 . A composition for promoting the carnitine palmitoyltransferase activity characterized by comprising the green coffee bean extract as an active substance.
24 . A composition for promoting the carnitine palmitoyltransferase activity of claim 23 , therein the green coffee bean extract is a polar solvent extract derived from the defatted green coffee beans.
25 . A composition for promoting the carnitine palmitoyltransferase activity of claim 24 , therein the polar solvent extract is a hydroethanol extract.
26 . A composition for promoting the carnitine palmitoyltransferase activity of claim 24 , therein the polar solvent extract is a hydroethanol extract having an ethanol concentration of 40 to 90% (wt/wt).
27 . A composition for promoting the carnitine palmitoyltransferase activity of claim 24 , therein the defatted green coffee bean is prepared by extracting and separating the oil from the green coffee beans with N-hexane
28 . A food and drink comprising a composition as an active substance for promoting the carnitine palmitoyltransferase activity described in claim 23 .
29 . A medicine comprising a composition as an active substance for promoting the carnitine palmitoyltransferase activity described in claim 23 .
30 . A composition for inhibiting the α-glucosidase activity comprising the green coffee bean extract as an active substance.
31 . A composition for inhibiting the α-glucosidase activity of claim 30 , therein the green coffee bean extract is a polar solvent extract derived from the defatted green coffee beans.
32 . A composition for inhibiting the α-glucosidase activity of claim 31 , therein the polar solvent extract is a hydroethanol extract.
33 . A composition for inhibiting the α-glucosidase activity of claim 31 , therein the polar solvent extract is a hydroethanol extract having an ethanol concentration of 40 to 90% (wt/wt).
34 . A composition for inhibiting the α-glucosidase activity of claim 31 , therein the defatted green coffee bean is prepared by extracting and separating the oil from the green coffee beans with N-hexane.
35 . A food and drink comprising a composition as an active substance for inhibiting the α-glucosidase activity described in claim 30 .
36 . A medicine comprising a composition as an active substance for inhibiting the α-glucosidase activity described in claim 30 .Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.